$84.09
00.00%
Pre-Market: Jul 19, 5:08 PM EDT
15 minutes delayed
Comments
Loading...
Biomarin Pharmaceutical
BMRNNASDAQ
Biomarin Pharmaceutical (BMRN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Speculative
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Biomarin Pharmaceutical (NASDAQ:BMRN) Stock Quotes, Forecast and News Summary
Biomarin Pharmaceutical Stock (NASDAQ: BMRN) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 36.00 / 2.59M |
| Day Range | - - - |
| 52 Wk Range | 73.68 - 99.56 |
| Market Cap | $15.97B |
| P/E Ratio | 79.33 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 54 |
| Short Interest | 4.47% |
| Days to Cover | 1.54 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Biomarin Pharmaceutical Inc.
Sector
Health Care
Industry
Biotechnology
BioMarin's focus is on rare-disease therapies. Genzyme markets Aldurazyme through its joint venture ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biomarin Pharmaceutical (BMRN) stock?
You can purchase shares of Biomarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.
Who are Biomarin Pharmaceutical (BMRN) competitors?
Other companies in Biomarin Pharmaceutical’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
What is the target price for Biomarin Pharmaceutical (BMRN) stock?
There is no analysis for Biomarin Pharmaceutical.
What is the forecast for Biomarin Pharmaceutical (BMRN) stock?
Biomarin Pharmaceutical has a consensus price target of $107.16.
Current stock price for Biomarin Pharmaceutical (BMRN)?
The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $84.09 last updated July 19, 2024 at 5:08 PM EDT.
Does Biomarin Pharmaceutical (BMRN) pay a dividend?
There are no upcoming dividends for Biomarin Pharmaceutical.
When is Biomarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?
Biomarin Pharmaceutical’s Q2 earnings are confirmed for Friday, August 2, 2024.
Is Biomarin Pharmaceutical (BMRN) going to split?
There is no upcoming split for Biomarin Pharmaceutical.
What sector and industry does Biomarin Pharmaceutical (BMRN) operate in?
Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.